1. Dilok Piyayotai
Information acquired: 2025
Dilok Piyayotai is an academic who published a paper in 2024-07 entitled Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation. The paper was published in a journal entitled European Heart Journal — Cardiovascular Pharmacotherapy.